\
&
Contact us
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The OpenVerse project aims at integrating knowledge, experts and actors around the creation of inclusive, open and ethically responsible European Virtual Worlds. This is done in alignment with the European Commission’s strategy on Web 4.0 and Virtual Worlds. As part its work, OpenVerse is conducting a landscaping exercise of initiatives... read more
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment EIC
The STEP funding dashboard is an interactive guide, offering a continuously updated state-of-play of funding opportunities supported by the EU budget and dedicated to projects related to strategic technologies contributing to STEP objectives. STEP seeks to reinforce, leverage and steer EU funds – existing and new – to in... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.